top of page

ABOUT US

CT is specialized in the development of new technologies in the fields of antibody-drug conjugates and cancer immunotherapies.

CEO
Stephen LaMond, PharmD, MBA

Executive Chair
William Heiden

Steve.jpeg

© 2018  COREA THERAPEUTICS,INC. All Rights Reserved.

bottom of page